STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression

Haematologica

Volumn 99, Issue 7, 2014, Pages

  Ohgami, Robert S ^a   Ma, Lisa ^a   Monabati, Ahmad ^b   Zehnder, James L ^a   Arber, Daniel A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b SHIRAZ UNIVERSITY   (Iran)

Author keywords

Anaplastic large cell lymphoma; B cell lymphoma unclassifiable with features intermediate between DLBCL and Burkitt lymphoma; CD30; Diffuse large B cell lymphoma; STAT3

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; GENOMIC DNA; STAT3 PROTEIN;

ADOLESCENT; ADULT; AGED; B CELL LYMPHOMA; BURKITT LYMPHOMA; CLASSICAL HODGKIN LYMPHOMA; DNA SEQUENCE; EXON; FEMALE; FOLLICULAR LYMPHOMA; GENE; GENE MUTATION; GENE TRANSLOCATION; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; MITOSIS RATE; PROTEIN EXPRESSION; STAT3 GENE; VERY ELDERLY; YOUNG ADULT; ADVERSE EFFECTS; ANIMAL; BONE MARROW TRANSPLANTATION; DISEASE MODEL; GENETICS; HEMATOLOGIC DISEASE; MUTATION; MYELOPROLIFERATIVE DISORDER;

ANIMALS; BONE MARROW TRANSPLANTATION; DISEASE MODELS, ANIMAL; HEMATOLOGIC NEOPLASMS; HUMANS; MUTATION; MYELOPROLIFERATIVE DISORDERS; STAT3 TRANSCRIPTION FACTOR;

EID: 84903578166     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2013.101543     Document Type: Letter

References (15)

1. Silva CM. Role of STATs as downstream signal transducers in src family kinase-mediated tumorigenesis. Oncogene. 2004;23(48): 8017-23.
2. Minegishi Y, Saito M. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome. Ann NY Acad Sci. 2011; 1246:34-40.
3. Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048-57.
4. Ohgami RS, Ma L, Merker JD, Martinez B, Zehnder JL, Arber DA. STAT3 mutations are frequent in CD30+ T-cell lymphomas and Tcell large granular lymphocytic leukemia. Leukemia. 2013;27 (11)2244-7
5. Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012;366 (20):1905-13.
6. Couronne L, Scourzic L, Pilati C, et al. STAT3 mutations identified in human hematological neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model. Haematologica. 2013;98(11)1748-52.
7. Valera A, Colomo L, Martinez A, et al. ALK-positive large B-cell lymphomas express a terminal B-cell differentiation program and activated STAT3 but lack MYC rearrangements. Mod Pathol. 2013;26(10):1329-37.
8. Kiuchi N, Nakajima K, Ichiba M, et al. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J Exp Med. 1999;189(1):63-73.
9. Cartwright P, McLean C, Sheppard A, Rivett D, Jones K, Dalton S. LIF/STAT3 controls ES cell self-renewal and pluripotency by a mycdependent mechanism. Development. 2005;132(5):885-96.
10. Wu ZL, Song YQ, Shi YF, Zhu J. High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma. J Hematol Oncol. 2011;4(1):31.
11. Ding BB, Yu JJ, Yu RY, et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood. 2008;111(3):1515-23.
12. Hazan-Halevy I, Harris D, Liu Z, et al. STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells. Blood. 2010;115(14):2852-63.
13. Daigle D, Megyola C, El-Guindy A, et al. Upregulation of STAT3 marks burkitt lymphoma cells refractory to epstein-barr virus lytic cycle induction by HDAC inhibitors. J Virol. 2010;84(2):993-1004.
14. Huang X, Meng B, Iqbal J, et al. Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol. 2013;31(86)4520-8.
15. Chiarle R, Voena C, Ambrogio C, Piva R, Inghirami G. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008;8(1):11-23.